Old Drug Turned ‘Cash Cow’ as Company Pumped Price to $40K a Vial, Emails Show
The CEO of Mallinckrodt Pharmaceuticals defended the price hikes of Acthar gel, an orphan drug that treats infantile spasms at a House Oversight Committee hearing on Thursday.